CytRx Corporation Reports 2010 Financial Results

March 11, 2011 |

1 min read

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today reported financial results for the 12 months ended December 31, 2010, and provided a business update.

Earnings

MORE ON THIS TOPIC

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Pfizer, Geron Downsize To Streamline Costs

December 12, 2025

·

95 min read

·

BioSpace Editorial Staff

Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.

Weight loss

Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech

December 11, 2025

·

2 min read

·

Tristan Manalac

Pictured: Pfizer's signage outside its office in Canada/iStock, JHVEPhoto

Layoffs

Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report

December 11, 2025

·

2 min read

·

Tristan Manalac

Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.

Immunology and inflammation

Novartis Unites With Relation in $1.7B Inflammatory Skin Disease Pact

December 9, 2025

·

2 min read

·

Tristan Manalac